Yiheng Capital Management, L.P. — 13F Holdings & Portfolio

CIK 1447228 · latest 13F-HR filed 2026-08-14

Yiheng Capital Management, L.P. manages $291.3M in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NOAH (23.04%), BILI (8.71%), EDU (8.45%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions, exited 2, added to 10, and trimmed 10.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
101 CALIFORNIA STREET
SUITE 2880
San Francisco, CA 94111
Phone
(415) 582-6306
Filing Manager
Yiheng Capital Management, L.P.
SAN FRANCISCO, CA
Signatory
Janet Ji
CCO & CFO
Loading holdings…
AUM

$291.3M

Long-equity book

Holdings

32

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+3 / −2 / ↑10 / ↓10

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • BILIBILI INC$8.7M +52.0%
  • SILVACO GROUP INC$4.7M +61.0%
  • VIRIDIAN THERAPEUTICS INC$3.3M +80.2%
  • HINGE HEALTH INC$1.5M +13.3%
  • KYMERA THERAPEUTICS INC$1.2M +18.9%
Show all 10

Top Trims

  • NEW ORIENTAL ED & TECHNOLOGY-$13.8M -64.8%
  • H WORLD GROUP LTD-$2.8M -17.0%
  • ATRENEW INC-$2.6M -17.5%
  • JD.COM INC-$2.3M -13.4%
  • PONY AI INC-$1.6M -26.4%
Show all 10

New Positions

  • POWER SOLUTIONS INTL INC$5.2M
  • BIOAGE LABS INC$4.2M
  • TUNIU CORP$151.9K
Show all 3

Exited Positions

  • CELLEBRITE DI LTD$633.9K
  • TUNIU CORP$242.1K
Show all 2
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 NOAH HLDGS LTD NOAH 65487X102 $67.1M 23.04% 6,717,351 SH
2 BILIBILI INC BILI 090040106 $25.4M 8.71% 1,489,815 SH
3 NEW ORIENTAL ED & TECHNOLOGY Call EDU 647581206 $24.6M 8.45% 536,351 SH
4 JD.COM INC JD 47215P106 $15.0M 5.17% 590,513 SH
5 H WORLD GROUP LTD HTHT 44332N106 $13.5M 4.63% 323,371 SH
6 HINGE HEALTH INC HNGE 433313103 $13.0M 4.45% 156,190 SH
7 SILVACO GROUP INC SVCO 82728C102 $12.5M 4.29% 906,381 SH
8 ATRENEW INC RERE 00138L108 $12.2M 4.20% 3,163,117 SH
9 BILL HOLDINGS INC BILL 090043100 $8.1M 2.77% 222,820 SH
10 JD.COM INC Call JD 47215P106 $7.6M 2.62% 3,000 SH
11 NEW ORIENTAL ED & TECHNOLOGY EDU 647581206 $7.5M 2.58% 1,636 SH
12 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $7.4M 2.53% 400,464 SH
13 KYMERA THERAPEUTICS INC KYMR 501575104 $7.3M 2.50% 63,440 SH
14 TAL ED GROUP TAL 874080104 $7.3M 2.49% 759,240 SH
15 JD.COM INC Call JD 47215P106 $6.4M 2.19% 2,500 SH
16 JD.COM INC Call JD 47215P106 $6.4M 2.19% 2,500 SH
17 JOYY INC JOYY 46591M109 $5.6M 1.94% 85,583 SH
18 BILIBILI INC Call BILI 090040106 $5.3M 1.83% 3,136 SH
19 BILIBILI INC Call BILI 090040106 $5.3M 1.81% 3,094 SH
20 POWER SOLUTIONS INTL INC PSIX 73933G202 $5.2M 1.78% 133,500 SH
21 PONY AI INC PONY 732908108 $4.5M 1.56% 653,215 SH
22 BIOAGE LABS INC BIOA 09077V100 $4.2M 1.43% 170,532 SH
23 FULL TRUCK ALLIANCE CO LTD YMM 35969L108 $4.2M 1.43% 513,248 SH
24 TRIP COM GROUP LTD TCOM 89677Q107 $3.5M 1.21% 88,112 SH
25 YATSEN HLDG LTD YSG 985194208 $3.0M 1.03% 946,193 SH
26 AGORA INC API 00851L103 $2.9M 0.99% 725,795 SH
27 DBV TECHNOLOGIES S A DBVT 23306J309 $2.8M 0.96% 170,142 SH
28 ZEPP HEALTH CORPORATION ZEPP 98945L204 $1.1M 0.39% 220,501 SH
29 JD.COM INC Call JD 47215P106 $1.1M 0.39% 443 SH
30 BEAM THERAPEUTICS INC BEAM 07373V105 $725.0K 0.25% 21,126 SH
31 PASSAGE BIO INC PASG 702712209 $420.2K 0.14% 86,097 SH
32 TUNIU CORP TOUR 89977P205 $151.9K 0.05% 31,443 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $291.3M 32 0001420506-26-001804
2026-03-31 2026-05-15 $230.7M 24 0001420506-26-001131
2025-12-31 2026-02-17 $494.3M 24 0001420506-26-000563
2025-09-30 2025-11-14 $678.1M 27 0001420506-25-003340